Silica nanoparticles in transmucosal drug delivery

43Citations
Citations of this article
115Readers
Mendeley users who have this article in their library.

Abstract

Transmucosal drug delivery includes the administration of drugs via various mucous membranes, such as gastrointestinal, nasal, ocular, and vaginal mucosa. The use of nanoparticles in transmucosal drug delivery has several advantages, including the protection of drugs against the harsh environment of the mucosal lumens and surfaces, increased drug residence time, and enhanced drug absorption. Due to their relatively simple synthetic methods for preparation, safety profile, and possibilities of surface functionalisation, silica nanoparticles are highly promising for transmucosal drug delivery. This review provides a description of silica nanoparticles and outlines the preparation methods for various core and surface-functionalised silica nanoparticles. The relationship between the functionalities of silica nanoparticles and their interactions with various mucous membranes are critically analysed. Applications of silica nanoparticles in transmucosal drug delivery are also discussed.

Cite

CITATION STYLE

APA

Ways, T. M. M., Ng, K. W., Lau, W. M., & Khutoryanskiy, V. V. (2020, August 1). Silica nanoparticles in transmucosal drug delivery. Pharmaceutics. MDPI AG. https://doi.org/10.3390/pharmaceutics12080751

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free